ELASMOGEN LIMITED
Company number SC467513 · Monitor this company
Executive summary
Elasmogen Limited is a clinical-stage biopharmaceutical company leveraging its proprietary soloMER™ platform to develop novel biologics for oncology and inflammatory diseases, supported by institutional investors and a scientifically credentialed board. The company's strategic value hinges on converting its IP portfolio and existing collaborative revenue streams into clinical milestones that attract partnership and acquisition interest, while managing the fundamental biotech challenge of sustained capital intensity. The post-year-end funding round provides near-term runway, but the company must accelerate toward value-inflection data points to reduce its dependency on successive equity raises and strengthen its negotiating position in a competitive single-domain antibody landscape.
Shareholders' funds
-£358,868
Balance sheet as at 2017-01-31
What it does
The principal activity of the company continued to be that of research and development work.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-01-15
- Employees
- 11 (2026 accounts · was 17 in 2025)
- Registered office
- Liberty Building, Foresterhill, Aberdeen, AB25 2ZP
- Postcode
- AB25 2ZP
- Capital
- 30 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2026-01-31
- Next due by
- 2027-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-01-15
- Next due by
- 2027-01-29
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 10 resigned
Group structure
Controlled by BGF INVESTMENT MANAGEMENT LIMITED — since 2022-04-29
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA152105 (Tier 1), registered since 2015.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- elasmogen.com
- Phone
- 07077210755
A biopharmaceutical company developing next-generation soloMER™ biologics. Specialising in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Previous company names
| Name | Date changed |
|---|---|
| PACIFIC SHELF 1760 LIMITED | 2014-02-05 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 13 QUEENS ROAD, ABERDEEN, ABERDEENSHIRE, AB15 4YL | 2016-01-29 |
At this address
2nd largest employer
of 9 similar companies in AB, with 11 staff.
Competitors Aberdeen
This company ranks 17 among research and experimental development on biotechnology in Aberdeen.
The class of 2014
38%
of the 356 companies in this sector incorporated in 2014 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.